Insurance deductibles (typically $500$2,000) must be met first, making the initial months even costlier
This article was translated from Valor Econmico using an artificial intelligence tool under the supervision of the Valor International editorial team to ensure accuracy, clarity, and adherence to our editorial standards
For those looking at self-pay, we provide reasonable pricing options$99 for an initial evaluation and $75 for follow-ups, with Zepbound starting at $299 monthly
In 2017, the FDA approved Novo Nordisks Ozempic as a type 2 diabetes treatment, and in 2021 approved Wegovy as a version for chronic weight management in adults with diabetes
If approved, pills could lift capacity constraints and broaden adoption far beyond what cold-chain injectables alone can reach
I dont think theres anything wrong with it